Literature DB >> 16473126

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis.

M Kyrgiou1, G Koliopoulos, P Martin-Hirsch, M Arbyn, W Prendiville, E Paraskevaidis.   

Abstract

BACKGROUND: Conservative methods to treat cervical intraepithelial neoplasia and microinvasive cervical cancer are commonly used in young women because of the advent of effective screening programmes. In a meta-analysis, we investigated the effect of these procedures on subsequent fertility and pregnancy outcomes.
METHODS: We searched for studies in MEDLINE and EMBASE and classified them by the conservative method used and the outcome measure studied regarding both fertility and pregnancy. Pooled relative risks and 95% CIs were calculated with a random-effects model and interstudy heterogeneity was assessed with Cochrane's Q test.
FINDINGS: We identified 27 studies. Cold knife conisation was significantly associated with preterm delivery (<37 weeks; relative risk 2.59, 95% CI 1.80-3.72, 100/704 [14%] vs 1494/27 674 [5%]), low birthweight (<2500 g; 2.53, 1.19-5.36, 32/261 [12%] vs 905/13 229 [7%]), and caesarean section (3.17, 1.07-9.40, 31/350 [9%] vs 22/670 [3%]). Large loop excision of the transformation zone (LLETZ) was also significantly associated with preterm delivery (1.70, 1.24-2.35, 156/1402 [11%] vs 120/1739 [7%]), low birthweight (1.82, 1.09-3.06, 77/996 [8%] vs 49/1192 [4%]), and premature rupture of the membranes (2.69, 1.62-4.46, 48/905 [5%] vs 22/1038 [2%]). Similar but marginally non-significant adverse effects were recorded for laser conisation (preterm delivery 1.71, 0.93-3.14). We did not detect significantly increased risks for obstetric outcomes after laser ablation. Although severe outcomes such as admission to a neonatal intensive care unit or perinatal mortality showed adverse trends, these changes were not significant.
INTERPRETATION: All the excisional procedures to treat cervical intraepithelial neoplasia present similar pregnancy-related morbidity without apparent neonatal morbidity. Caution in the treatment of young women with mild cervical abnormalities should be recommended. Clinicians now have the evidence base to counsel women appropriately.

Entities:  

Mesh:

Year:  2006        PMID: 16473126     DOI: 10.1016/S0140-6736(06)68181-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  220 in total

1.  The role of prophylactic cerclage in preventing preterm delivery after electrosurgical conization.

Authors:  Mi-Young Shin; Eun-Sung Seo; Suk-Joo Choi; Soo-Young Oh; Byoung-Gie Kim; Duk-Soo Bae; Jong-Hwa Kim; Cheong-Rae Roh
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

2.  Performance of implementing guideline-driven cervical cancer screening measures in an inner-city hospital system.

Authors:  Daryl L Wieland; Laura L Reimers; Eijean Wu; Lisa M Nathan; Tammy Gruenberg; Maria Abadi; Mark H Einstein
Journal:  J Low Genit Tract Dis       Date:  2011-10       Impact factor: 1.925

3.  Clinical significance of early (< 20 weeks) vs. late (20-24 weeks) detection of sonographic short cervix in asymptomatic women in the mid-trimester.

Authors:  E Vaisbuch; R Romero; O Erez; J P Kusanovic; S Mazaki-Tovi; F Gotsch; V Romero; C Ward; T Chaiworapongsa; P Mittal; Y Sorokin; S S Hassan
Journal:  Ultrasound Obstet Gynecol       Date:  2010-10       Impact factor: 7.299

4.  High risk HPV testing following treatment for cervical intraepithelial neoplasia.

Authors:  M Molloy; R Comer; P Rogers; M Dowling; P Meskell; K Asbury; M O'Leary
Journal:  Ir J Med Sci       Date:  2015-12-21       Impact factor: 1.568

5.  Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study.

Authors:  Evangelos Paraskevaidis; Antonios Athanasiou; Maria Paraskevaidi; Evripidis Bilirakis; Georgios Galazios; Emmanuel Kontomanolis; Konstantinos Dinas; Aristotelis Loufopoulos; Maria Nasioutziki; Ioannis Kalogiannidis; Apostolos Athanasiadis; Alexios Papanikolaou; Anastasia Vatopoulou; Gregorios Grimbizis; Dimitrios Tsolakidis; Alexandros Daponte; George Valasoulis; Stella Gritzeli; Georgios Michail; Georgios Adonakis; Minas Paschopoulos; Orestis Tsonis; Maria-Eugenia Anaforidou; Anna Batistatou; Maria Kyrgiou
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 6.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

7.  Cervical intraepithelial neoplasia and higher long term risk of cancer.

Authors:  Guglielmo Ronco; Mario Giovanni Sideri; Stefano Ciatto
Journal:  BMJ       Date:  2007-10-24

8.  Human papillomavirus-related gynecologic neoplasms: screening and prevention.

Authors:  Whitfield B Growdon; Marcela Del Carmen
Journal:  Rev Obstet Gynecol       Date:  2008

9.  Cervical carcinoma rates among young females in the United States.

Authors:  Vicki B Benard; Meg Watson; Philip E Castle; Mona Saraiya
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

10.  Human papillomavirus in high-grade cervical lesions: Austrian data of a European multicentre study.

Authors:  Lucia Rössler; Olaf Reich; Reinhard Horvat; Sabrina Collas de Souza; Katsyarina Holl; Elmar A Joura
Journal:  Wien Klin Wochenschr       Date:  2013-09-17       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.